




Medizia Biotech is a trusted Critical Care Medicine Manufacturer in India, dedicated to developing and manufacturing high-quality injectable formulations for hospitals, healthcare institutions, and pharmaceutical companies. Based in Jagadhri, Haryana, the company operates with WHO-GMP, ISO 9001:2015, and DCGI certifications, ensuring every product meets stringent national and international quality standards.
The company specializes in a broad portfolio of critical care injectables, including antibiotics, gastroenterology injections, cardiology injections, anesthesia products, antifungal injections, anti-malarial medicines, NSAIDs, analgesics, corticosteroids, and other intensive care formulations. Its advanced manufacturing facility is supported by a dedicated Quality Control and Analytical Research Laboratory, enabling consistent product quality, safety, and regulatory compliance.
In addition to manufacturing, Medizia Biotech provides comprehensive Third-Party Manufacturing and PCD Pharma Franchise services with monopoly rights, competitive pricing, promotional support, and timely product delivery. The company serves both domestic and international markets while maintaining a strong focus on innovation, customer satisfaction, and ethical business practices.
With 300+ products, modern manufacturing infrastructure, experienced professionals, and a commitment to improving patient outcomes, Medizia Biotech continues to strengthen its position among the best Critical Care Medicine Manufacturers in India.
Medizia Biotech maintains a dedicated Quality Control and Analytical Research Laboratory, ensuring every critical care medicine undergoes rigorous testing for safety, purity, effectiveness, and regulatory compliance.
To develop innovative, high-quality critical care medicines that improve patient outcomes while delivering reliable pharmaceutical solutions through advanced technology and ethical business practices.
To become one of the world's most trusted critical care pharmaceutical companies by delivering innovative injectable formulations and maintaining the highest standards of quality and excellence.
N/A